Role of prolactin in B cell regulation in multiple sclerosis

Journal of Neuroimmunology

Volumn 269, Issue 1-2, 2014, Pages 76-86

  Correale, Jorge ^a   Farez, Mauricio F ^a   Ysrraelit, María Célica ^a  

^a FLENI   (Argentina)

Author keywords

Autoimmunity; B cells; Hormones; Multiple sclerosis; Prolactin

Indexed keywords

APOPTOSIS REGULATORY PROTEIN; B CELL ACTIVATING FACTOR; CD40 ANTIGEN; JANUS KINASE 2; PROLACTIN; PROTEIN BCL 2; PROTEIN TRP63; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HORMONE ACTION; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

AUTOIMMUNITY; B CELLS; HORMONES; MULTIPLE SCLEROSIS; PROLACTIN;

ADULT; B-LYMPHOCYTES; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PROLACTIN;

EID: 84896399213     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2014.02.007     Document Type: Article

References (67)

1. Abo S., Bernard C., Webb M., Jhons T.G., Alafaci A., Ward L.D., Simpson R.J., Kerlero de Rosbo N. Preparation of highly purified human myelin oligodendrocyte glycoprotein in quantities sufficient for encephalitogenicity and immunogenicity studies. Biochem. Mol. Biol. Int. 1993, 30:945-958.
2. Adamson A.D., Friederichsen S., Semprini S., Harper C.V., Mullins J.J., White M.R.H., Davis J.R. Human prolactin gene promoter regulation by estrogen: convergence with tumor necrosis factor-α signaling. Endocrinology 2008, 149:687-694.
3. Ben-Jonathan N., Mershon J., Allen D., Steinmetz R. Extrapituitary prolactin: distribution, regulation, functions and clinical aspects. Endocr. Rev. 1996, 17:639-669.
4. Bouman A., Heineman M.J., Faas M. Sex hormones and the immune response in humans. Hum. Reprod. Updat. 2005, 11:411-423.
5. Buckley A. Prolactin, lymphocyte growth and survival factor. Lupus 2001, 10:684-690.
6. Canonico P.L., Sortino M.A., Favit A., Aleppo G., Scapagnini U. Dihydroergocryptine protects from acute experimental allergic encephalomyelitis in the rat. Funct. Neurol. 1993, 8:183-188.
7. Chrousos G.P. The hypothalamic-pituitary-adrenal axis and immune mediated inflammation. N. Engl. J. Med. 1995, 332:1351-1362.
8. Confavreux C., Hutchinson M., Hours M.M., Cortinovis-Tourniaire P., Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. N. Engl. J. Med. 1998, 339:285-291.
9. Correale J., Bassani Molinas M. Temporal variations of adhesion molecules and matrix metalloproteinases in the course of MS. J. Neuroimmunol. 2003, 140:198-209.
10. Correale J., Gilmore W., Li S., Walsh J., Bassani M.M., Lund B., Arias M., Weiner L.P. Resistance to glucocorticoid-induced apoptosis in PLP peptide-specific T cell clones from patients with progressive MS. J. Neuroimmunol. 2000, 109:197-210.
11. Correale J., Rush C., Amengual A., Goicochea M.T. Mitoxantrone as rescue therapy in worsening relapsing-remitting MS patients receiving IFN-beta. J. Neuroimmunol. 2005, 162:173-183.
12. Couse J.F., Korach K.S. Estrogen receptor null mice: what have we learned and where will they lead us?. Endocr. Rev. 1999, 20:358-417.
13. De Bellis A., Bizarro A., Pivonello R., Lombardi G., Bellastella A. Prolactin and autoimmunity. Pituitary 2005, 8:25-30.
14. Disanto G., Morahan J.M., Barnett M.H., Giovannoni G., Ramagopalan S.V. The evidence for a role of B cells in multiple sclerosis. Neurology 2012, 78:823-832.
15. Dong T., Tsai-Morris C.H., Dufau M.L. A novel estradiol estrogen receptor alpha-dependent transcriptional mechanism controls expression of the human prolactin receptor. J. Biol. Chem. 2006, 281:18825-18836.
16. Dörner T., Giesecke C., Lipsky P.E. Mechanisms of B cell autoimmunity in SLE. Arthritis Res. Ther. 2011, 13:243.
17. Fojtikova M., Tomasova Studynkova J., Filkova M., Lacinova Z., Gatterova J., Pavelka K., Vencovský J., Senolt L. Elevated prolactin levels in patients with rheumatoid arthritis: association with disease activity and structural damage. Clin. Exp. Rheumatol. 2010, 28:849-854.
18. Gagnerault M.C., Touraine P., Savino W., Kelly P.A., Dardenne M. Expression of prolactin receptors in murine lymphoid cells in normal and autoimmune situations. J. Immunol. 1993, 150:5673-5681.
19. Genain C.P., Nguyen M.H., Letvin N.L., Pearl R., Davis R.L., Adelman M., Lees M.B., Linington C., Hauser S.L. Antibody facilitation of multiple sclerosis-like lesions in a non human primate. J. Clin. Invest. 1995, 96:2966-2974.
20. Genain C.P., Canella B., Hauser S.L., Raine C.S. Identification of autoantibodies associated with myelin damage in multiple sclerosis. Nat. Med. 1999, 15:170-175.
21. Gleicher N., Barad D.H. Gender as risk factor for autoimmune diseases. J. Autoimmun. 2007, 28:1-6.
22. Goffin V., Binart N., Clement-Lacroix P., Bouchard B., Bole-Feysot C., Edery M., Lucas B.K., Touraine P., Pezet A., Maaskant R., Pichard C., Helloco C., Baran N., Favre H., Bernichtein S., Allamando A., Ormandy C., Kelly P.A. From the molecular biology of prolactin and its receptor to the lessons learned from knockout mice models. Genet. Anal. - Biomol. Eng. 1999, 15:189-201.
23. Gold R., Linington C., Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006, 129:1953-1971.
24. Gregg C. Pregnancy, prolactin and white matter regeneration. J. Neurol. Sci. 2009, 285:22-27.
25. Gregg C., Shikar V., Larsen P., Mak G., Chojnacki A., Yong V.W., Wiss S. White matter plasticity and enhanced remyelination in the maternal CNS. J. Neurosci. 2007, 27:1812-1823.
26. Grimaldi C.M. Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells. Curr. Opin. Rheumatol. 2006, 18:456-461.
27. Grimaldi C.M., Michael D.J., Diamond B. Cutting edge: expansion and activation of a population of autoreactive marginal zone B cells in a model of estrogen-induced lupus. J. Immunol. 2001, 167:1886-1890.
28. Haase C.G., Guggenmos J., Brehm U., Andersson M., Olsson T., Reindl M., Schneidewind J.M., Zettl U.K., Heindereich F., Berger T., Wekerle H., Hohlfeld R., Linington C. The fine specificity of the myelin oligodendrocyte glycoprotein autoantibody response in patients with multiple sclerosis and normal healthy controls. J. Neuroimmunol. 2001, 141:220-225.
29. Hauser S.L., Waubant E., Arnold D.L., Vollmer T., Antel J., Fox R.J., Bar-Or A., Panzara M., Sarkar N., Agarwal S., Langer-Gould A., Smith C.H., HERMES Trial Group B-cell depletion with Rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 2008, 358:676-688.
30. Hilton A.A., Slavin A.J., Hilton D.J., Bernard C.C. Characterization of cDNA and genomic clones encoding human myelin oligodendrocyte glycoprotein. J. Neurochem. 1995, 65:309-318.
31. Jacobi A.M., Rohde W., Ventz M., Riemekasten G., Burmester G.R., Hiepe F. Enhanced serum prolactin (PRL) in patients with systemic lupus erythematosus: PRL levels are related to the disease activity. Lupus 2001, 10:554-561.
32. Jara-Quezada L., Graef A., Lavalle C. Prolactin and gonadal hormones during pregnancy in systemic lupus erythematosus. J. Rheumatol. 1991, 18:349-353.
33. Jara L.J., Cruz-Cruz P., Saavedra M.A., Medina G., García-Flores A., Angeles U., Miranda-Limón J.M. Bromocriptine during pregnancy in systemic lupus erythematosus: a pilot clinical trial. Ann. N. Y. Acad. Sci. 2007, 1110:297-304.
34. Koch-Henriksen N., Sørensen P.S. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010, 9:520-532.
35. Langer-Gould A., Huang S.M., Gupta R., Leimpeter A.D., Greenwood E., Albers K.B., Van Den Eeden S.K., Nelson L.M. Exclusive breastfeeding and the risk of postpartum relapses in women with multiple sclerosis. Arch. Neurol. 2009, 66:958-963.
36. Ledesma-Soto Y., Blanco-Favela F., Fuentes-Pananá E.M., Tesoro-Cruz E., Hernández-González R., Arriaga-Pizano L., Legorreta-Haquet M.V., Montoya-Diaz E., Chávez-Sánchez L., Castro-Mussot M.E., Chávez-Rueda A.K. Increased levels of prolactin receptor expression correlate with the early onset of lupus symptoms and increased numbers of transitional-1B cells after prolactin treatment. BMC Immunol. 2012, 13:11. 10.1186/1471-2172-13-11.
37. Leondires M.P., Hu Z.Z., Dong J., Tsai-Morris C.H., Dufau M.L. Estradiol stimulates expression of two human prolactin receptor isoforms with alternative exons-1 in T47D breast cancer cells. J. Steroid Biochem. Mol. Biol. 2002, 82:263-268.
38. Linington C., Bradi M., Lassman H., Brunner C., Vass K. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein. Am. J. Pathol. 1988, 130:443-454.
39. Lyons J.A., San M., Happ M.P., Cross A.H. B-cells are critical to induction of experimental allergic encephalomyelitis by protein but not by a short encephalitogenic peptide. Eur. J. Immunol. 1999, 29:3432-3439.
40. Mayer M.C., Meinl E. Glycoproteins as targets of autoantibodies in CNS inflammation: MOG and more. Ther. Adv. Neurol. Disord. 2012, 5:147-159.
41. McFarland H.F., Martin R. Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 2007, 8:913-919.
42. McManus M.T., Sahrp P.A. Gene silencing in mammals by small interfering RNAs. Nat. Rev. Genet. 2002, 3:737-747.
43. Möderscheim T.A., Gorba T., Pathipati P., Kokay I.C., Grattan D.R., Williams C.E. Prolactin is involved in glial responses following a focal injury to the juvenile rat brain. Neuroscience 2007, 145:963-973.
44. Nagafuchi H., Suzuki N., Kaneko A., Asai T., Sakane T. Prolactin locally produced by synovium infiltrating T lymphocytes induces excessive synovial cell functions in patients with rheumatoid arthritis. J. Rheumatol. 1999, 26:1890-1900.
45. O'Connor K., Appel H., Bregoli L., Call M.E., Catz I., Chan J.A., Moore N.H., Warren K.G., Wong S.J., Hafler D.A., Wuchepfennig K.W. Antibodies from inflamed central nervous system tissue recognize myelin oligodendrocyte glycoprotein 2005.
46. Oellerich T., Bremes V., Neumann K., Bohnenberger H., Dittman K., Hsiao H.H., Engelke M., Schnyder T., Batista F.D., Urlaub H., Wienands J. The B- cell antigen receptor signal through a performed transducer module of SLP65 and CIN85. EMBO J. 2011, 30:3620-3634.
47. Østensen M., Villiger P.M., Förger F. Interaction of pregnancy and autoimmune rheumatic diseases. Autoimmun. Rev. 2012, 11:A437-A446.
48. Pakpoor J., Disanto G., Lacey M.V., Helwig K., Giovannon i G., Ramagopalan S.V. Breastfeeding and multiple sclerosis relapses: a meta-analysis. J. Neurol. 2012, 259:2246-2248.
49. Peeva E., Grimaldi C., Spatz L., Diamond B. Bromocriptine restores tolerance in estrogen-treated mice. J. Clin. Invest. 2000, 106:1373-1379.
50. Peeva E., Michael D., Cleary J., Rice J., Chen X., Diamond B. Prolactin modulates the naïve B cell repertoire. J. Clin. Invest. 2003, 111:275-283.
51. Picco P., Gattorno M., Buoncompagn i A., Facchetti P., Rossi G., Pistoia V. Prolactin and interleukin 6 in prepuberal girls with juvenile chronic arthritis. J. Rheumatol. 1998, 25:347-351.
52. Pierson E., Simmons S.B., Castelli L., Goverman J.M. Mechanisms regulating regional localization of inflammation during CNS autoimmunity. Immunol. Rev. 2012, 248:205-215.
53. Riskind P.N., Massacesi L., Doolottle T.H., Hauser S.L. The role of prolactin in autoimmune demyelination: suppression of experimental allergic encephalomyelitis by bromocriptine. Ann. Neurol. 1991, 29:542-547.
54. Saha S., Gonzalez J., Rosenfeld G., Keiser H., Peeva E. Prolactin alters the mechanisms of B cell tolerance induction. Arthritis Rheum. 2009, 60:1743-1752.
55. Serafini B., Rosicarelli B., Magliozzi R., Stigliano E., Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol. 2004, 14:164-174.
56. Shelly S., Boaz M., Orbach H. Prolactin and autoimmunity. Autoimmun. Rev. 2012, 11:A465-A470.
57. Tessier C., Deb S., Prigent-Tessier A., Ferguson-Gottschall S., Gibori G.B., Shiu R.P., Gibori G. Estrogen receptors α and β in rat decidua cells: cell-specific expression and differential regulation by steroid hormones and prolactin. Endocrinology 2000, 141:3842-3851.
58. Tseng L., Zhu H.H. Progestin, estrogen and insulin-like growth factor-I stimulate the prolactin receptor mRNA in human endometrial stromal cells. J. Soc. Gynecol. Investig. 1998, 5:149-155.
59. von Büdingen H.C., Hauser S.L., Fuhrmann A., Nabavi C.B., Lee J.I., Genain C.P. Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelination. Proc. Natl. Acad. Sci. 2002, 99:8207-8212.
60. Vidaller A., Gaudarrama F., Llorente L., Mendez J.P., Larrea F., Villa A.R., Alarcón-Segovia D. Hyperprolactinemia inhibits natural killer (NK) cell function in vivo and its bromocriptine treatment not only corrects it but makes it more efficient. J. Clin. Immunol. 1992, 12:210-215.
61. Walker S.E. Treatment of systemic lupus erythematosus with bromocriptine. Lupus 2001, 10:197-202.
62. Whitacre C.C., Reinold S.C., O'Looney P.A. A gender gap in autoimmunity. Science 1999, 283:1277-1278.
63. Wienands J., Schweiker J., Wollscheid B., Jumaa H., Nielsen P.J., Reth M. SLP-65: a new signaling component in B-lymphocytes which requires expression of the antigen receptor for phosphorylation. J. Exp. Med. 1998, 188:791-795.
64. Willemborg D.O., Prowse S.J. Immunoglobulin-deficient rats fail to develop experimental allergic encephalomyelitis. J. Neuroimmunol. 1983, 5:99-109.
65. Wilson F., Foster D. Textbook of Endocrinology 1992, WB Saunders, Philadelphia. 8th edition.
66. Yu-Lee L.Y. Prolactin modulation of immune and inflammatory responses. Recent Prog. Horm. Res. 2002, 57:435-455.
67. Zhornitsky S., Yong V.W., Weiss S., Metz L.M. Prolactin in multiple sclerosis. Mult. Scler. J. 2013, 19:15-23.